Drug Search Results
More Filters [+]

Pterostilbene

Alternative Names: pterostilbene
Latest Update: 2024-06-12
Latest Update Note: News Article

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | India

Approved Indications: None

Known Adverse Events: None

Company: Elysium Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pterostilbene

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Acute Kidney Injury

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT04342975

P2

Completed

Acute Kidney Injury

2024-03-14

Recent News Events